Breakthrough pain management

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4468 (2006.01) A61K 9/00 (2006.01) A61K 31/00 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2685231

The present disclosure is directed to a powdered formulation comprising an analgesic for use in pulmonary inhalation administration for the rapid analgesic titration of pain, in particular breakthrough pain. Upon administration, the powdered formulation is able to provide a narrower titration range in patients suffering from pain, as well as effective analgesic amounts in a shorter time and at lower dose levels when compared to the analgesic administered by an oral transmucosal route.

L'invention concerne une formulation pulvérulente comprenant un analgésique pour une utilisation dans l'administration par inhalation pulmonaire pour le titrage d'analgésique rapide de la douleur, en particulier la douleur aiguë. Lors de l'administration, la formulation pulvérulente peut fournir une plage de titrage plus étroite chez les patients souffrant d'une douleur, de même que des quantités d'analgésique efficaces en un temps plus court et à de plus faibles niveaux de dose par rapport à l'analgésique administré par voie orale transmuqueuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Breakthrough pain management does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Breakthrough pain management, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breakthrough pain management will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1643482

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.